05/16/2024
3:33 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:35 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:04 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:10 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
3:17 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
8:11 AM | Entrada Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
8:13 AM | Entrada Therapeutics (Filer)
| Form DEFA14A | |
|
04/29/2024
8:14 AM | Entrada Therapeutics (Filer)
| Form ARS | |
04/25/2024
3:30 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024
3:20 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/23/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 AM | Entrada Therapeutics (Filer)
| Form PRE 14A | |
04/18/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:16 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
3:23 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:35 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:14 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:12 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
4:16 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
3:17 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
3:31 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
4:57 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:31 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:36 AM | Entrada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
6:24 AM | Entrada Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
3:34 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:36 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:22 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:22 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:44 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:46 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:47 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:48 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:37 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:32 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:16 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:35 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
12/22/2023
3:38 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:26 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
3:40 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
4:25 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
4:24 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:38 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
4:14 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
6:00 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
6:35 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:35 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
6:20 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
6:01 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
4:27 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:35 PM | Entrada Therapeutics (Filer)
| Form 424B5 | |
09/29/2023
3:39 PM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
6:09 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:21 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:07 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:08 PM | Entrada Therapeutics (Issuer)
KREHER NERISSA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:09 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:31 PM | Chapman Gina (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:32 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
6:09 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:23 AM | Entrada Therapeutics (Filer)
| Form 10-K/A | |
08/08/2023
6:25 AM | Entrada Therapeutics (Filer)
| Form 10-Q/A | |
08/08/2023
6:07 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:14 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:32 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:33 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:34 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:11 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
3:12 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
3:32 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:20 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:46 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:12 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
3:18 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
3:27 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:11 PM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
